KLOW is a multi-pathway recovery and restoration blend designed for structured use where tissue support, repair, inflammation control, and broader restoration are all priorities within the same protocol. By combining TB-500, BPC-157, GHK-Cu, and KPV into a single vial, KLOW is positioned as a broader-spectrum support compound for users looking beyond simple injury support alone.

This blend is typically used where the goal is to support recovery across multiple systems at once, including soft tissue, connective tissue, training wear-and-tear, inflammation-driven irritation, and skin or tissue quality. It fits well into recovery-focused protocols, post-strain support phases, or general restoration runs where repair and resilience are the primary objectives.

How It Works

TB-500

TB-500 is commonly used in recovery protocols for its association with cellular migration, tissue remodelling, and support following strain, repetitive loading, or soft-tissue irritation. It is often included where mobility, tissue recovery, and restoration speed are priorities.

BPC-157

BPC-157 is widely used in structured recovery protocols where tendon, ligament, gut, and general soft-tissue support are part of the goal. It is frequently selected for repair-focused use and is commonly paired with TB-500 for more complete recovery support.

GHK-Cu

GHK-Cu is the dominant compound in this formula and adds a different dimension to the blend. It is typically associated with tissue renewal, skin support, collagen-related repair signalling, and broader regenerative applications. In KLOW, it shifts the formula from a simple recovery blend into a more complete restoration and tissue-quality support protocol.

KPV

KPV is commonly used where inflammation modulation, irritation control, and gut or skin-calming support are relevant. Its inclusion helps round out the formula where excessive inflammatory signalling may be slowing recovery or contributing to discomfort, irritation, or poor tissue quality.

Combined Rationale

Together, these four compounds create a more complete recovery blend than any one of them alone. KLOW is structured to support repair, restoration, inflammation control, and tissue quality in one protocol, making it suitable for users looking for a broader recovery tool rather than a narrow single-purpose peptide.

Reconstitution Guideline

Total vial content: 80mg

• TB-500: 10mg
• BPC-157: 10mg
• GHK-Cu: 50mg
• KPV: 10mg

Suggested reconstitution: 2mL bacteriostatic water

Resulting approximate concentration per mL:

• TB-500: 5mg/mL
• BPC-157: 5mg/mL
• GHK-Cu: 25mg/mL
• KPV: 5mg/mL

Insulin syringe reference:

• 0.05mL = TB-500 250mcg + BPC-157 250mcg + GHK-Cu 1.25mg + KPV 250mcg
• 0.10mL = TB-500 500mcg + BPC-157 500mcg + GHK-Cu 2.5mg + KPV 500mcg
• 0.15mL = TB-500 750mcg + BPC-157 750mcg + GHK-Cu 3.75mg + KPV 750mcg
• 0.20mL = TB-500 1mg + BPC-157 1mg + GHK-Cu 5mg + KPV 1mg
• 0.25mL = TB-500 1.25mg + BPC-157 1.25mg + GHK-Cu 6.25mg + KPV 1.25mg

This dilution creates a more concentrated blend and keeps daily draw volumes smaller and cleaner.

Dosage Protocol

KLOW is best positioned as a daily recovery and restoration blend, with dose selection based on how aggressively the protocol is being run and how broad the support goal is.

Conservative Starting Structure

A common starting protocol is:

0.10mL once daily
This provides:
TB-500 500mcg
BPC-157 500mcg
GHK-Cu 2.5mg
KPV 500mcg

This structure suits general recovery support, irritation control, and lower-intensity restoration-focused use.

Standard Active Protocol

A more typical full-use protocol is:

0.15mL once daily
This provides:
TB-500 750mcg
BPC-157 750mcg
GHK-Cu 3.75mg
KPV 750mcg

This is likely the most balanced daily protocol for the blend and gives meaningful exposure across all four components without becoming excessive.

Higher-Intensity Protocol

For heavier training wear-and-tear, more active recovery periods, or more deliberate repair-focused use:

0.20mL once daily
This provides:
TB-500 1mg
BPC-157 1mg
GHK-Cu 5mg
KPV 1mg

This places the blend into a stronger support range and is better suited to shorter, more focused runs.

Run Length

A typical run length is:

• 4 to 6 weeks for general support
• 6 to 8 weeks for more deliberate recovery or restoration-focused use

A short break after a full run is often used before repeating the protocol.

Expected Outcomes

• Improved recovery from training wear-and-tear
• Broader soft-tissue and connective-tissue support
• Irritation and inflammation control
• Support during tendon, ligament, or strain-focused recovery phases
• Improved skin and tissue-quality support
• A more complete recovery protocol than TB-500 or BPC-157 alone
• Restoration-focused use where both internal recovery and visible tissue quality matter

Because the formula includes a meaningful amount of GHK-Cu, KLOW may appeal not only to recovery-focused users but also to those looking for a stronger regenerative or tissue-quality support angle.

Stacking / Pairing

KLOW is already a comprehensive blend in its own right, but it can still be positioned alongside complementary products depending on the broader goal.

Often Paired With

• CJC / Ipamorelin blends for recovery, sleep, and GH-axis support
• Tesamorelin-based protocols where abdominal composition and recovery are part of a wider physique or restoration plan
• Fat-loss protocols where tissue support and recovery capacity need to be maintained during a calorie deficit
• General wellness or restoration support products where inflammation, gut stress, or tissue fatigue are part of the broader picture

KLOW works particularly well as a foundation recovery blend inside a larger physique, repair, or restoration protocol.

Cautions

• Reconstituted product should be refrigerated after mixing.
• Sterile technique should be used during reconstitution and handling.
• A conservative starting structure is generally preferred when assessing tolerance.
• Because this is a multi-compound blend, protocol intensity should be matched to actual need rather than pushed unnecessarily high.
• Not suitable for use where any component is contraindicated.

Related Products

• TB-500
• BPC-157
• GHK-Cu
• KPV
• CJC / Ipamorelin blends
• Tesamorelin
• Recovery-support and body-composition protocols